Newsroom

First injectable nanoparticle generator could radically transform metastatic breast cancer treatment

A team of investigators from Houston Methodist Research Institute may have transformed the treatment of metastatic triple negative breast cancer by creating the first drug to successfully eliminate lung metastases in mice. This landmark study appears today in Nature Biotechnology (early online edition).
Read more

FIRST RAPID DETECTION ZIKA TEST NOW AVAILABLE THROUGH COLLABORATION WITH TEXAS CHILDREN’S HOSPITAL AND HOUSTON METHODIST HOSPITAL

Collaboration between two Texas Medical Center institutions has resulted in today’s release of the country’s first hospital-based rapid tests for the Zika virus.
Read More

DEMENTIA TREATMENT DELAYED DUE TO MISDIAGNOSIS
Using specialized PET imaging, researchers at Houston Methodist are able to identify accumulations of the protein beta amyloid in the brain of Alzheimer's patients, shown in yellow in the scan on the left. Beta amyloid is not present in the brains of patients with frontotemporal dementia, as shown in the scan on the right.

Many patients showing signs of dementia are quickly diagnosed with Alzheimer’s disease when they might actually suffer from frontotemporal dementia, delaying the appropriate treatment for them.
Read more

Latest News
Thursday, April 21, 2016 Houston Methodist researchers identify key factor for reprogramming adult cells into stem cells
In a new Cell Reports paper, a team led by John P. Cooke, M.D., Ph.D., of the Houston Methodist Research Institute, has identified and characterized a biological factor critical to the transformation of adult somatic cells (cells that are not sperm or egg cells) into stem cells. “Think about the ca...
Read more